Dainippon Sumitomo Halts Study Of Drug For Advanced Colorectal Cancer
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo said it was dropping its development of a drug as a treatment for advanced colorectal cancer after it failed to meet targets in Phase III trials.